Kyeong Ho Yun
Overview
Explore the profile of Kyeong Ho Yun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
41.
Lee Y, Suh Y, Kim J, Cho Y, Yun K, Kim Y, et al.
Korean Circ J
. 2022 Feb;
52(4):324-337.
PMID: 35129317
Background And Objectives: Identifying patients with high bleeding risk (HBR) is important when making decisions for antiplatelet therapy strategy. This study evaluated the impact of ticagrelor monotherapy after 3-month dual...
42.
Park S, Yun K, Cho J, Lee S
Chonnam Med J
. 2021 Oct;
57(3):204-210.
PMID: 34621641
Potent antiplatelet therapy after primary percutaneous coronary intervention (PCI) has the potential to reduce infarct size. This study analyzed the association between on-treatment platelet reactivity and myocardial infarct size in...
43.
Roh J, Hahn J, Oh J, Chun W, Park Y, Jang W, et al.
Cardiol J
. 2021 Sep;
28(6):855-863.
PMID: 34523115
Background: It remains unclear whether P2Y12 monotherapy, especially clopidogrel, following short-duration dual antiplatelet therapy (DAPT) is associated with favorable outcomes in patients undergoing complex percutaneous coronary intervention (PCI). Therefore, this...
44.
Jang W, Lee S, Her S, Moon D, Moon K, Yoo K, et al.
Ann Saudi Med
. 2021 Aug;
41(4):191-197.
PMID: 34420394
Background: Tobacco smoking and its harmful health effects also increase economic burdens globally. Surprisingly, despite the detrimental health consequences of smoking, some studies have shown better survival among smokers compared...
45.
Hong S, Kim J, Hong S, Lim D, Lee S, Yun K, et al.
JACC Cardiovasc Interv
. 2021 Aug;
14(16):1801-1811.
PMID: 34332946
Objectives: The aim of this study was to determine whether 1 month of dual-antiplatelet therapy (DAPT) followed by aspirin monotherapy after polymer-free drug-coated stent (PF-DCS) implantation is noninferior to 6...
46.
Lee S, Lee S, Chun W, Song Y, Choi S, Jeong J, et al.
EuroIntervention
. 2021 May;
17(11):e888-e897.
PMID: 34031020
Background: Although P2Y12 inhibitor monotherapy has emerged as a promising alternative for dual antiplatelet therapy (DAPT), there remains concern regarding the safety of clopidogrel monotherapy. Aims: We sought to investigate...
47.
Lee S, Her S, Jang W, Moon D, Moon K, Yoo K, et al.
Heart Vessels
. 2021 Apr;
36(11):1617-1625.
PMID: 33837813
The aim of this study was to investigate the impact of chronic total occlusion (CTO) on clinical outcomes in patients with calcified coronary lesions receiving rotational atherectomy (RA). This multi-center...
48.
Lee S, Cho J, Yun K, Oh S
Can J Cardiol
. 2021 Mar;
37(8):1278-1280.
PMID: 33775877
A 65-year-old man developed 3-vessel stent thrombosis after percutaneous coronary intervention with aspirin and clopidogrel. Platelet tests revealed clopidogrel resistance, which resolved after changing clopidogrel to ticagrelor. Although routine platelet...
49.
Kim J, Jang W, Lee W, Choi K, Lee J, Park T, et al.
Heart
. 2021 Mar;
107(13):1077-1083.
PMID: 33758008
Objective: To compare P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) with 12-month DAPT according to the type of P2Y12 inhibitor in patients undergoing percutaneous coronary intervention (PCI). Methods:...
50.
Cho J, Lee S, Yun K, Kim B, Hong S, Ko J, et al.
J Am Heart Assoc
. 2021 Mar;
10(7):e019630.
PMID: 33739127
Background There is a lack of data on factors that are related to clinically relevant bleeding after ticagrelor treatment. We investigated the clinical and procedural factors related to major bleeding...